AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 96 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $255,000 | -83.7% | 506,326 | -25.6% | 0.00% | – |
| Q1 2022 | $1,566,000 | -52.2% | 680,964 | -1.4% | 0.00% | -100.0% |
| Q4 2021 | $3,279,000 | -34.8% | 690,573 | +9.1% | 0.00% | -50.0% |
| Q3 2021 | $5,030,000 | +19.6% | 632,833 | +4.8% | 0.00% | +100.0% |
| Q2 2021 | $4,205,000 | -10.4% | 604,112 | +1.8% | 0.00% | -50.0% |
| Q1 2021 | $4,694,000 | +10.4% | 593,417 | +9.9% | 0.00% | 0.0% |
| Q4 2020 | $4,250,000 | +20.0% | 540,042 | +8.1% | 0.00% | 0.0% |
| Q3 2020 | $3,541,000 | -23.2% | 499,458 | +0.1% | 0.00% | 0.0% |
| Q2 2020 | $4,613,000 | +87.5% | 498,714 | -5.5% | 0.00% | +100.0% |
| Q1 2020 | $2,460,000 | -39.3% | 527,814 | -0.5% | 0.00% | 0.0% |
| Q4 2019 | $4,054,000 | -1.6% | 530,648 | -1.0% | 0.00% | -50.0% |
| Q3 2019 | $4,122,000 | +15.8% | 535,960 | +3.1% | 0.00% | +100.0% |
| Q2 2019 | $3,559,000 | -1.9% | 519,610 | +15.3% | 0.00% | 0.0% |
| Q1 2019 | $3,627,000 | +69.2% | 450,591 | +57.4% | 0.00% | 0.0% |
| Q4 2018 | $2,144,000 | +34.7% | 286,225 | +72.1% | 0.00% | 0.0% |
| Q3 2018 | $1,592,000 | +63.8% | 166,321 | +81.1% | 0.00% | – |
| Q2 2018 | $972,000 | +6.7% | 91,848 | 0.0% | 0.00% | – |
| Q1 2018 | $911,000 | +364.8% | 91,848 | +153.9% | 0.00% | – |
| Q4 2017 | $196,000 | +206.2% | 36,169 | +168.0% | 0.00% | – |
| Q3 2017 | $64,000 | – | 13,497 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yu Fan | 20,592 | $347,798 | 24.67% |
| VR Adviser, LLC | 295,034 | $3,614,167 | 0.38% |
| IFP Advisors, Inc | 2,860 | $1,718 | 0.00% |